The invention relates to antisense oligonucleotidic sequences (ODN) againstSmad7 suitably modified, and their uses in medical field as therapeuticbiological agents, in particular in the treatment of chronic inflammatorybowel disease, such as Crohn~s disease and ulcerative colitis.